Global Atopic Dermatitis Treatment Market Size, Share & Trends Analysis Report by Drug Class (Corticosteroids, PDE-4 Inhibitor, Emollients, Calcineurin Inhibitors, Antibiotics, Others) by Route of Administration (Oral, Topical, and Injectable), Forecast Period (2020-2026)
The atopic dermatitis treatment market is anticipated to showcase a considerable growth rate during the forecast period. According to the American Academy of Dermatology, atopic dermatitis, a major type of eczema affects up to 25% of children, and an estimated 60% of people with eczema develop it during the first year of their life. The high prevalence of atopic dermatitis among children is anticipated to contribute to market growth.
The atopic dermatitis treatment market is segmented on the basis of drug class and route of administration. Based on the drug class, the atopic dermatitis market is segmented into corticosteroids, emollients, calcineurin inhibitors, antibiotics, and others. Based on the route of administration, the market is segmented into oral, topical, and injectable. Topical is anticipated to hold major market share based on the route of the administration.
Geographically, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is anticipated to hold the considerable market share in the atopic dermatitis treatment market due to the high awareness of the drugs for the treatment of market in the region. Asia-Pacific is the fastest-growing region in the market. The increasing prevalence of the disorder in the emerging economies of Asia-Pacific is a key factor contributing to the growth of the market in the region.
The key players of the atopic dermatitis treatment market include Pfizer, Inc., LEO Pharma A/S, Mylan N.V., Bausch Health Companies Inc., Bayer HealthCare AG, Encore Dermatology, Inc., AbbVie Inc., Allergan PLC, GlaxoSmithKline PLC, and so on. The major players of the atopic dermatitis market are making hefty investments in the R&D of new drugs. The continuous efforts of the market players in the development of new drugs are driving the growth of the global atopic dermatitis market.
Research Methodology
The market study of the global atopic dermatitis treatment market is incorporated by extensive primary and secondary research conducted. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.
In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.
Secondary Sources Include
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
1. Global Atopic Dermatitis Treatment Market Research and Analysis by Type
2. Global Atopic Dermatitis Market Treatment Research and Analysis by Route of Administration
The Report Covers
The atopic dermatitis treatment market is anticipated to showcase a considerable growth rate during the forecast period. According to the American Academy of Dermatology, atopic dermatitis, a major type of eczema affects up to 25% of children, and an estimated 60% of people with eczema develop it during the first year of their life. The high prevalence of atopic dermatitis among children is anticipated to contribute to market growth.
The atopic dermatitis treatment market is segmented on the basis of drug class and route of administration. Based on the drug class, the atopic dermatitis market is segmented into corticosteroids, emollients, calcineurin inhibitors, antibiotics, and others. Based on the route of administration, the market is segmented into oral, topical, and injectable. Topical is anticipated to hold major market share based on the route of the administration.
Geographically, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is anticipated to hold the considerable market share in the atopic dermatitis treatment market due to the high awareness of the drugs for the treatment of market in the region. Asia-Pacific is the fastest-growing region in the market. The increasing prevalence of the disorder in the emerging economies of Asia-Pacific is a key factor contributing to the growth of the market in the region.
The key players of the atopic dermatitis treatment market include Pfizer, Inc., LEO Pharma A/S, Mylan N.V., Bausch Health Companies Inc., Bayer HealthCare AG, Encore Dermatology, Inc., AbbVie Inc., Allergan PLC, GlaxoSmithKline PLC, and so on. The major players of the atopic dermatitis market are making hefty investments in the R&D of new drugs. The continuous efforts of the market players in the development of new drugs are driving the growth of the global atopic dermatitis market.
Research Methodology
The market study of the global atopic dermatitis treatment market is incorporated by extensive primary and secondary research conducted. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.
In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.
Secondary Sources Include
- Financial reports of companies involved in the market.
- Whitepapers, research-papers, and news blogs.
- Company websites and their product catalog.
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
1. Global Atopic Dermatitis Treatment Market Research and Analysis by Type
2. Global Atopic Dermatitis Market Treatment Research and Analysis by Route of Administration
The Report Covers
- Comprehensive research methodology of the global atopic dermatitis treatment market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global atopic dermatitis treatment market.
- Insights about market determinants which are stimulating the global atopic dermatitis treatment market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Table of Contents
1. Report Summary
2. Market Overview and Insights
3. Competitive Landscape
4. Market Determinants
5. Market Segmentation
6. Regional Analysis
7. Company Profiles
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
A selection of companies mentioned in this report includes:
- AbbVie, Inc.
- Allergan PLC
- Bausch Health Companies, Inc.
- Bayer HealthCare AG
- Beiersdorf, Inc.
- Encore Dermatology, Inc.
- Eli Lily and Co.
- Galderma laboratories, L.P.
- GlaxoSmithKline PLC
- LEO Pharma A/S
- Mylan N.V.
- Novartis International AG
- Pfizer, Inc.
- Regenron Pharmaceutical, Inc.
- Sanofi S.A.
